# Regeneron Pharmaceuticals - Regeneron Pharmaceuticals, Inc. (REGN)

Stock code REGN · Yahoo ticker REGN · Sector: Healthcare

Overall fundamentals score: 54/100 (Okay). Top 50% of scored stocks.

## Pillar scores

| Pillar | Score | Status |
|---|---|---|
| Business Strength | 60/100 | Okay |
| Financial Safety | 100/100 | Strong |
| Cash & Dividends | 50/100 | Okay |
| Price Fairness | 0/100 | Weak |
| Risk | 58/100 | Okay |

## Every measure

Regeneron Pharmaceuticals (REGN): Overall score: 54/100 (Okay)

Business Strength: 60/100 (Okay)
Return on Equity (ROE) 14% - Okay
4-Year Revenue Growth +6%/yr - Okay
4-Year Profit Growth +3%/yr - Okay
Net Profit Margin 28% - Strong
Quarterly Momentum +9% - Okay

Financial Safety: 100/100 (Strong)
Debt-to-Equity 0.1× - Strong
Current Ratio 3.3× - Strong
Interest Coverage 94.3× - Strong

Cash & Dividends: 50/100 (Okay)
Dividend Quality 0% - Weak
Operating Cash Flow Positive but bumpy - Okay
Free Cash Flow Positive & growing - Strong
Cash & Cash Equivalents Partly healthy - Okay

Price Fairness: 0/100 (Weak)
P/E Ratio 22.1× - Weak
P/B Ratio 3× - Weak
PEG Ratio 7.2 - Weak

Risk: 58/100 (Okay)
Earnings Consistency Steady - Strong
Debt Trend (4yr) Stable - Okay
Share Count Trend (4yr) -2%/yr - Strong
Inventory vs Sales (4yr) +0.3 pp/yr vs sales - Okay
Asset Turnover Trend (4yr) -6.1% - Okay
Quarterly Consistency 3 of 4 quarters down - Weak

## Common questions

### What is Regeneron Pharmaceuticals's fundamentals score?

Regeneron Pharmaceuticals (REGN) scores 54/100 (Okay) on Score Your Stock's educational fundamentals model: in the top 50% of 503 scored S&P 500 stocks.

### Which pillar is Regeneron Pharmaceuticals strongest and weakest on?

Its strongest pillar is Financial Safety (100/100); its weakest is Price Fairness (0/100).

### How does Regeneron Pharmaceuticals rank against its sector?

Regeneron Pharmaceuticals ranks #30 of 60 scored Healthcare stocks on Score Your Stock.

### Does Regeneron Pharmaceuticals pay dividends?

Yes. Regeneron Pharmaceuticals (REGN) has a dividend yield of 0.4%, from dividends with an ex-date in the last 12 months. It pays out 9% of its profit as dividends. That payout is at least 3 times its best earlier year, so it is likely a one-off rather than a regular dividend. Its Cash & Dividends pillar scores 50/100.

### How do I buy Regeneron Pharmaceuticals shares?

From Malaysia, open an account with a broker that offers US shares (many local and app-based brokers do), convert ringgit to US dollars, then buy REGN. US shares trade one share at a time, not in lots of 100. Check the currency conversion fee and US dividend tax (usually 30% withheld for Malaysians) before you buy.

### How is this score calculated?

The overall score pools every measure across 5 weighted pillars: Business Strength, Financial Safety, Cash & Dividends, Price Fairness, and Risk. It uses the same rules as our Bursa scores. For banks, Financial Safety checks nonaccrual (impaired) loans, loan loss coverage and the CET1 capital ratio, from the FDIC call report of the group's main bank. Full methodology and the default weights: https://scoreyourstock.com/how. This is an educational tool, not investment advice.

### What is Regeneron Pharmaceuticals (REGN), in plain English?

Regeneron Pharmaceuticals (REGN) is a Healthcare company (Biotechnology). On Score Your Stock's fundamentals check, it scores 54/100, rated Okay. Its biggest strength is Financial Safety (100/100); its main watch-out is Price Fairness (0/100). Shares currently cost about 22 years of its current profit to buy (P/E 22.1×). Full breakdown and daily-updated score: https://scoreyourstock.com/stocks/us/regn-regeneron-pharmaceuticals

Market data as of 31 Oct 2026.
Full page with charts and explanations: https://scoreyourstock.com/stocks/us/regn-regeneron-pharmaceuticals
Educational tool, not investment advice. Data isn't real-time.